Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_729ac72bc03053dfb64ff7dc881c541a |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-567 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-18 |
filingDate |
2019-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03832d91dcbb5f40b3a5d47f2e672585 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fc9970d0da490ab6619220c3bc712a2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbefdee6a2037af1b10eecdd74b60e52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01415a1b94ed1968a76df0140964645c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a85ba7661aaac380a5ebad122da5067 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e6de55d451abfc64f63bdbb47890557 |
publicationDate |
2021-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-112675180-A |
titleOfInvention |
A kind of ethinyl estradiol drug co-crystal and its preparation method and application |
abstract |
The invention discloses an ethinylestradiol drug co-crystal. The drug co-crystal takes ethinyl estradiol as an active ingredient and imidazole as a co-crystal former, and the two are connected by hydrogen bonds. The molecular formula of the drug co-crystal is C 23 H 28 N 2 O 2 . The ethinyl estradiol drug co-crystal has good water solubility and bioavailability. The invention also discloses a preparation method and application of the ethinylestradiol drug co-crystal. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114478673-A |
priorityDate |
2019-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |